Search research articles
Contact Us
Filters
Showing results (291-300 of 361) with videos related to
Page
of 37
Sort By:
Experimental Hematology
|
July 5, 2003
Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation
Annette B Kraus, Juanita Shaffer, Han Chong Toh, et al.
Transplantation
|
June 24, 2006
Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation
Robert A Cina, Krzysztof J Wikiel, Patricia W Lee, et al.
The Oncologist
|
July 17, 2021
Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients
Annabelle J Anandappa, Gabriela S Hobbs, Bimalangshu R Dey, et al.
Frontiers in Immunology
|
April 9, 2020
Inflammasome Adaptor ASC Is Highly Elevated in Lung Over Plasma and Relates to Inflammation and Lung Diffusion in the Absence of Speck Formation
Mikhail A Gavrilin, Christian C McAndrew, Evan R Prather, et al.
Bone Marrow Transplantation
|
July 1, 2008
Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT
D T Ting, T R Spitzer, A Chaudhary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 18, 2014
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation
Albert C Yeh, Andrew M Brunner, Thomas R Spitzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 21, 2007
Phase I trial of parathyroid hormone to facilitate stem cell mobilization
Karen K Ballen, Elizabeth J Shpall, David Avigan, et al.
Transplantation
|
November 27, 2002
Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease
Leo H Bühler, Thomas R Spitzer, Megan Sykes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2013
Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience
Aazim K Omer, Panayiotis D Ziakas, Theodora Anagnostou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience
Matthew Ulrickson, Julie Aldridge, Haesook T Kim, et al.
Page
of 37
Search research articles
Search
Showing results (291-300 of 361) with videos related to
Sort By:
Page
of 37
Experimental Hematology
|
July 5, 2003
Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation
Annette B Kraus, Juanita Shaffer, Han Chong Toh, et al.
Transplantation
|
June 24, 2006
Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation
Robert A Cina, Krzysztof J Wikiel, Patricia W Lee, et al.
The Oncologist
|
July 17, 2021
Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients
Annabelle J Anandappa, Gabriela S Hobbs, Bimalangshu R Dey, et al.
Frontiers in Immunology
|
April 9, 2020
Inflammasome Adaptor ASC Is Highly Elevated in Lung Over Plasma and Relates to Inflammation and Lung Diffusion in the Absence of Speck Formation
Mikhail A Gavrilin, Christian C McAndrew, Evan R Prather, et al.
Bone Marrow Transplantation
|
July 1, 2008
Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT
D T Ting, T R Spitzer, A Chaudhary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 18, 2014
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation
Albert C Yeh, Andrew M Brunner, Thomas R Spitzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 21, 2007
Phase I trial of parathyroid hormone to facilitate stem cell mobilization
Karen K Ballen, Elizabeth J Shpall, David Avigan, et al.
Transplantation
|
November 27, 2002
Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease
Leo H Bühler, Thomas R Spitzer, Megan Sykes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2013
Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience
Aazim K Omer, Panayiotis D Ziakas, Theodora Anagnostou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2009
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience
Matthew Ulrickson, Julie Aldridge, Haesook T Kim, et al.
Page
of 37